IgA vasculitis associated with Covid-19 infection in a pediatric patient, a case report
Abstract
Background: IgA vasculitis is a non-granulomatous small-vessel vasculits of unknown etiology, Infections have been associated with disease onset, however studies have not been conclusive in this regard. The current pandemic caused by Type 2 severe acute respiratory syndrome virus has shown to have significant clinical heterogeneity. Systemic vasculitis such as IgA vascuitis may be a manisfestation of SARsCOV2. Few cases of this association have been reported, mainly in the pediatric population.
Case report: We report the case of a 6-year-old pediatric patient who came to the emergency department for purpuric dermatosis, joint pain, fever and evidence systemic inflammation by laboratory. PCR was positive for SARS COV-2.
Conclusion. The previous case represents a rare clinical manifestation associated with SARS COV-2. More studies are required to understand the interaction of this virus with the immune pathways that can trigger the development of IgA-associated vasculitis.
Downloads
References
(1) Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterization [published correction appears in Ann Rheum Dis. 2011 Feb;70(2):397. Paut, Isabelle Kone [corrected to KonePaut, Isabella]]. Ann Rheum Dis. 2010;69(5):790- 797. doi:10.1136/ard.2009.116624
(2) Sabui TK, Chanudhuri JE, Sing S, Gupta A. Henoch Schönlein Purpura: Pediatric Rheumatology. 3rd Edition. Delhi: Peepee Publishers and Distributors (P) Ltd; 2019:188-191.
(3) Reid-Adam J. Henoch-Schonlein purpura. Pediatric Rev. 2014;35(10):447-449. doi:10.1542/pir.35-10-447.
(4) Oni L, Sampath S. Childhood IgA Vasculitis (Henoch Schonlein Purpura) - Advances and Knowledge Gaps. Front Pediatric. 2019;7:257. Published 2019 Jun 27. doi:10.3389/fped.2019.00257.
(5) Adeyinka A, Bailey K, Pierre L, Kondamudi N. COVID 19 infection: Pediatric perspectives. JACEP Open. 2021;2:e12375. https://doi.org/10.1002/emp2.12375
(6) Wang C, Worswick S. Cutaneous manifestations of COVID-19: Dermatology Online Journal. 2021;27(1):1-38.
(7) Yu HQ, Sun BQ, Fang ZF, Zhao JC, Liu XY, Li YM, et al. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J. 2020;56(2):2001526. Published 2020 Aug 27. doi:10.1183/13993003.01526-2020.
(8) AlGhoozi DA, AlKhayyat HM. A child with Henoch- Schonlein purpura secondary to a COVID-19 infection. BMJ Case Rep. 2021;14(1):e239910. Published 2021 Jan 6. doi:10.1136/ bcr-2020-239910.
(9) Suso AS, Mon C, Oñate Alonso I, Galindo Romo K, Juarez RC, et al. IgA vasculitis with nephritis (Henoch-Schönlein Purpura) in a COVID-19 patient. Kidney Int Rep. 2020;5(11):2074-2078. doi:10.1016/j.ekir.2020.08.016.
(10) Sandhu S, Chand S, Bhatnagar A, Dabas R, Bhat S, Kumar H, et al. Possible association between IgA vasculitis and COVID-19. Derma tol Ther. 2021;34(1):e14551. doi:10.1111/dth.14551.
(11) Allez M, Denis B, Bouaziz JD, Battistella M, Zagdanski AM,
Bayart J, et al. COVID-19-Related IgA Vasculitis. Arthritis Rheuma- tol. 2020;72(11):1952-1953. doi:10.1002/art.41428.
Copyright (c) 2021 Paraguayan Journal of Rheumatology
This work is licensed under a Creative Commons Attribution 4.0 International License.
